Browse AMR Mutations

Explore antimicrobial resistance mutations from the literature

Gene	Protein Change	Nucleotide Change	Mechanism	Organism	Resistance To	Database	Validation Status
aac(6')-Ib aminoglycoside 6'-N acetyltransferase	L55Q	CTG->CAG	-	-	isepamicin	Reslit	Candidate
aac(6')-Ib aminoglycoside 6'-N-acetyltransferase	N159A	-	-	E. coli	kanamycin\|amikacin	Reslit	Candidate
aac(6')-Ib aminoglycoside 6'-N-acetyltransferase	P155A	-	-	E. coli	kanamycin\|amikacin	Reslit	Candidate
aac(6')-Ib aminoglycoside 6'-N-acetyltransferase	P157A	-	-	E. coli	kanamycin\|amikacin	Reslit	Candidate
aac(6')-Ib aminoglycoside 6'-N acetyltransferase	Q101L	CAG->CTG	-	-	amikacin	Reslit	Candidate
aac(6')-Ib aminoglycoside 6'-N-acetyltransferase	Q106L	-	-	Salmonella enterica	aminoglycosides\|fluoroquinolones	Reslit	Candidate
aac(6')-Ib aminoglycoside N-acetyltransferase	S117L	-	increased resistance to amikacin and reduced resistance to gentamicin	Escherichia coli, Klebsiella, Escherichia, E. coli	aminoglycosidesciprofloxacin\|kanamycin	Reslit	Candidate
aac(6')-Ib aminoglycoside 6'-N acetyltransferase	S7T	TCA->ACT	-	-	isepamicin	Reslit	Candidate
aac(6')-Ib aminoglycoside 6'-N acetyltransferase	S83N	TCA->AAC	-	-	isepamicin	Reslit	Candidate
aac(6')-Ib aminoglycoside N-acetyltransferase	W102R	-	confers additional resistance against piperazine-containing fluoroquinolones	Escherichia coli, Klebsiella, Escherichia, E. coli	fluoroquinolonesciprofloxacin\|kanamycin	Reslit	Candidate